+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


OncBioMune Pharmaceuticals Inc (OBMP) - Financial and Strategic SWOT Analysis Review


OncBioMune Pharmaceuticals Inc (OncBioMune), formerly Quint Media Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The company’s products comprise biosimilars and vaccines developed for various cancer types such as breast, prostrate, renal and ovarian cancer. Its lead product ProscaVax, a therapeutic vaccine is developed for prostate cancer patients; and OvcaVax for treating ovarian cancer. The company utilizes Targeted Transferrin Transport Technology to deliver cytotoxic agents targeted selectively to the cancer cell, and reduce effect on normal cells. It attacks iron metabolism of cancer cells and prevent iron storage into the protein ferritin with its technology. The company also has a portfolio of targeted therapies including paclitaxel. OncBioMune is headquartered in Baton Rouge, Louisiana, the US.

OncBioMune Pharmaceuticals Inc Key Recent Developments

Jun 28, 2017: OncBioMune Pharmaceuticals Establishes Another Revenue Stream; Schedules First Patient with AAT Deficiency for Treatment in Mexico
Mar 27, 2017: OncBioMune Sales of Bekunis and Cirkused Exceed Forecast by 164 Percent in First Six Months on Market

This comprehensive SWOT profile of OncBioMune Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OncBioMune Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • OncBioMune Pharmaceuticals Inc - Key Information
  • OncBioMune Pharmaceuticals Inc - Overview
  • OncBioMune Pharmaceuticals Inc - Key Employees
  • OncBioMune Pharmaceuticals Inc - Key Employee Biographies
  • OncBioMune Pharmaceuticals Inc - Key Operational Heads
  • OncBioMune Pharmaceuticals Inc - Major Products and Services
  • OncBioMune Pharmaceuticals Inc - History
  • OncBioMune Pharmaceuticals Inc - Company Statement
  • OncBioMune Pharmaceuticals Inc - Locations And Subsidiaries
  • OncBioMune Pharmaceuticals Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • OncBioMune Pharmaceuticals Inc - Business Description
  • OncBioMune Pharmaceuticals Inc - Corporate Strategy
  • OncBioMune Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • OncBioMune Pharmaceuticals Inc - Strengths
  • OncBioMune Pharmaceuticals Inc - Weaknesses
  • OncBioMune Pharmaceuticals Inc - Opportunities
  • OncBioMune Pharmaceuticals Inc - Threats
  • OncBioMune Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • OncBioMune Pharmaceuticals Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • OncBioMune Pharmaceuticals Inc, Key Information
  • OncBioMune Pharmaceuticals Inc, Key Ratios
  • OncBioMune Pharmaceuticals Inc, Share Data
  • OncBioMune Pharmaceuticals Inc, Major Products and Services
  • OncBioMune Pharmaceuticals Inc, History
  • OncBioMune Pharmaceuticals Inc, Key Employees
  • OncBioMune Pharmaceuticals Inc, Key Employee Biographies
  • OncBioMune Pharmaceuticals Inc, Key Operational Heads
  • OncBioMune Pharmaceuticals Inc, Other Locations
  • OncBioMune Pharmaceuticals Inc, Subsidiaries
  • OncBioMune Pharmaceuticals Inc, Key Manufacturing facilities
  • OncBioMune Pharmaceuticals Inc, Key Competitors
  • OncBioMune Pharmaceuticals Inc, SWOT Analysis
  • OncBioMune Pharmaceuticals Inc, Ratios based on current share price
  • OncBioMune Pharmaceuticals Inc, Annual Ratios
  • OncBioMune Pharmaceuticals Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • OncBioMune Pharmaceuticals Inc, Performance Chart
  • OncBioMune Pharmaceuticals Inc, Ratio Charts
Note: Product cover images may vary from those shown